{"id":"W4408958060","doi":"10.1056/nejmoa2416112","title":"Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism","year":2025,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University Health Network; Ottawa Hospital; University of Ottawa","funders":"Bristol-Myers Squibb","keywords":"Apixaban; Venous thromboembolism; Medicine; Cardiology; Cancer; Internal medicine; Thrombosis; Warfarin; Atrial fibrillation; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002219031,0.0004632755,0.001804788,0.000247418,0.0001630853,0.0004666687,0.0005609262,0.0006586955,0.002413107],"category_scores_gemma":[0.00347544,0.0002165321,0.0008750953,0.0002749038,0.0006069948,0.0004114645,0.0002801258,0.001320402,0.0002123015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003313099,"about_ca_system_score_gemma":0.0007363079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000162766,"about_ca_topic_score_gemma":0.0003130107,"domain_scores_codex":[0.9986023,0.0009237203,0.0001574991,0.000124893,0.0001312701,0.00006024044],"domain_scores_gemma":[0.9978727,0.000866082,0.000659964,0.0001777665,0.0001145829,0.0003088941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.830808,0.006257544,0.008861426,0.003030202,0.002497499,0.0001465734,0.00009470838,0.002065017,0.009784549,0.0003495277,0.001068429,0.1350365],"study_design_scores_gemma":[0.7348772,0.2292015,0.02538278,0.0002499578,0.001801917,0.0005835592,0.00002864327,0.001801382,0.002243413,0.000517278,0.003282211,0.00003015009],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788494,0.01804981,0.0007123062,0.0005007362,0.0001850263,0.0007711035,0.0001820007,0.00003183524,0.0007177738],"genre_scores_gemma":[0.9935922,0.003978845,0.0009808693,0.0003041636,0.0002861565,0.0005134498,0.0001635725,0.000003452846,0.0001773051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002413107,"threshold_uncertainty_score":0.0117355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02382418614570202,"score_gpt":0.3350331201582877,"score_spread":0.3112089340125856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}